Fidelis Capital Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$686K Sell
8,102
-62
-0.8% -$5K 0.04% 292
2026
Q1
$577K Buy
8,164
+855
+12% +$64K 0.04% 301
2025
Q4
$577K Buy
7,309
+558
+8% +$44.2K 0.04% 283
2025
Q3
$556K Buy
6,751
+3,138
+87% +$247K 0.04% 280
2025
Q2
$274K Buy
3,613
+180
+5% +$13.9K 0.03% 365
2025
Q1
$258K Sell
3,433
-39
-1% -$3.24K 0.03% 349
2024
Q4
$297K Buy
3,472
+228
+7% +$19K 0.03% 334
2024
Q3
$273K Sell
3,244
-70
-2% -$5.23K 0.03% 335
2024
Q2
$228K Sell
3,314
-138
-4% -$9.85K 0.03% 331
2024
Q1
$256K Buy
+3,452
New +$241K 0.04% 318
2023
Q4
– Sell
-3,686
Closed -$232K – 335
2023
Q3
$232K Buy
+3,686
New +$230K 0.08% 236

Other funds holding MET

Fidelis Capital Partners's MET Position: Q2 2026 in Review

Fidelis Capital Partners reduced its MetLife (MET) stake by 0.76% in Q2 2026, selling an estimated $5K and leaving 8,102 shares worth $686K. The position accounts for 0.04% of the portfolio, ranked #292.

Fidelis Capital Partners first reported a position in MET in Q3 2023 and has held it in 11 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Fidelis Capital Partners held 8,102 shares of MetLife worth $686K as of Q2 2026.
  • Fidelis Capital Partners sold 62 MetLife shares in Q2 2026, an estimated $5K.
  • MetLife made up 0.04% of Fidelis Capital Partners's portfolio in Q2 2026, its #292 holding.
  • Fidelis Capital Partners first reported a position in MetLife in Q3 2023 and has held it in 11 quarters since.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.